Alcohol and Other Drugs

According to the World Health Organisation, harmful use of alcohol accounted for approximately three million deaths in 2016, which represents 5.3 per cent of all deaths.

Harmful use of alcohol is a causal factor for more than 200 disease and injury conditions.

About 5.5% of the global population used psychoactive drugs in 2018, with 35 million people estimated to be affected by drug use disorders which, untreated, increase morbidity and mortality risk, and can trigger substantial suffering and the impairment of personal, social, family and occupational functioning.

Burnet is committed to addressing the health impacts of alcohol and other drug use through the application of behavioural and clinical research, treatment practice and community-based harm reduction programs based on sound evidence.

Donate today!

Use my gift where the need is greatest

Current Projects

  • Attitudes to drug use among East African migrants in Melbourne’s western suburbs

  • Breaking the cycle: supporting people with drug use histories to avoid reincarceration

  • Coping with COVID-19: Young people’s health and wellbeing in Australia

  • CREIDU: Centre for Research Excellence into Injecting Drug Use

  • EDRS: Ecstasy and related Drugs Reporting System

  • Engaging men to improve family health and prevent gender-based violence

  • Evaluation of the Multicultural Drug and Alcohol Service

  • Examining interventions targeting high-risk drinking among young Australians

  • Exploring alcohol and other drug use among migrant communities in Victoria

  • Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

  • IDRS: Illicit Drug Reporting System

  • Needle and Syringe Program (NSP) Snapshot Study

  • New media and technology in health promotion practice

  • Sex, Drugs, and Rock'n'Roll (Big Day Out Study)

  • SHARP: Sexual Health And Risk Prevention Study

  • SuperMIX: The Melbourne Injecting Drug User Cohort Study

  • The International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

  • The oral health of people who inject drugs (PWID)

  • The PharmEC REACH study

  • TRYP: Transitions and Risk in Young People project

Past Projects

  • PATH Cohort Study

  • Smartphone apps for alcohol health promotion

  • The Drug Policy Modelling Program (DPMP)

  • Victorian Pharmaceutical Opioid Monitoring Project